Getinge AB
Company Profile
Business description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Contact
Lindholmspiren 7A
P.O. Box 8861
GothenburgSE-417 56
SWET: +46 103350000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
11,874
Stocks News & Analysis
stocks
Short-term pain for long-term gain for undervalued ASX share
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,010.10 | 117.10 | -1.28% |
CAC 40 | 7,654.25 | 53.65 | -0.70% |
DAX 40 | 23,487.33 | 550.00 | -2.29% |
Dow JONES (US) | 45,295.81 | 249.07 | -0.55% |
FTSE 100 | 9,116.69 | 79.65 | -0.87% |
HKSE | 25,304.47 | 192.08 | -0.75% |
NASDAQ | 21,279.63 | 175.92 | -0.82% |
Nikkei 225 | 41,938.89 | 371.60 | -0.88% |
NZX 50 Index | 13,074.81 | 58.35 | -0.44% |
S&P 500 | 6,415.54 | 44.72 | -0.69% |
S&P/ASX 200 | 8,738.80 | 120.20 | -1.36% |
SSE Composite Index | 3,802.77 | 55.36 | -1.43% |